Skip to content

Clinical trials

Recruiting Pulmonary Arterial Hypertension trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Recruiting Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20181
20223
20231
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese Pulmonary Vascular Disease Research Group3
Actelion1
China National Center for Cardiovascular Diseases1
China-Japan Friendship Hospital1
ChromX Health1
Nanjing First Hospital, Nanjing Medical University1
Pulnovo Medical (Wuxi) Co., Ltd.1
Qianfoshan Hospital1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai Zhongshan Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension12
Hypertension, Pulmonary5
Disease2
Pulmonary Embolism2
Asthma1
Bronchiectasis1
Bronchitis1
Cystic Fibrosis1
Emphysema1
Lung Abscess1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.